Novel Approaches for the Treatment of the Patient with Resistant Hypertension: Renal Nerve Ablation

Overview

Journal Curr Cardiovasc Risk Rep

Publisher Springer

Specialty Cardiology & Vascular Diseases

Date 2013 Nov 19

PMID 24244757

Citations 4

Authors

Vinay Gulati

William B White

Affiliations

Soon will be listed here.

Abstract

Sympathetic innervation of the kidneys plays a major role in the pathogenesis of hypertension through modulation of renin secretion, glomerular filtration rate and renal absorption of sodium. Targeted interventions for renal nerve ablation are being developed for treatment of drug resistant hypertension in the USA and rest of the world. Early studies with the use of radiofrequency based renal denervation systems have shown encouraging results with significant reduction of blood pressure in patients inadequately controlled despite nearly maximal drug therapy regimens. Thus far, the renal denervation procedure has been associated with minimal side effects. Long term efficacy and safety beyond 3 years needs to be determined for renal nerve ablation. This review focuses on the physiology of the renal sympathetic system, the rationale for renal nerve ablation and current evidence in support of the available therapeutic renal denervation systems.

Citing Articles

Efficacy and safety of 3D reconstruction and basket multi-electrode renal denervation (RDN) for refractory hypertensive patients with chronic kidney disease.

Cai H, Fang Z, Wu X, Zhou W, Lin J, Peng F J Clin Hypertens (Greenwich). 2024; 26(4):338-348.

PMID: 38430475 PMC: 11007785. DOI: 10.1111/jch.14781.

Epididymal Fat-Derived Sympathoexcitatory Signals Exacerbate Neurogenic Hypertension in Obese Male Mice Exposed to Early Life Stress.

Dalmasso C, Leachman J, Ghuneim S, Ahmed N, Schneider E, Thibault O Hypertension. 2021; 78(5):1434-1449.

PMID: 34601958 PMC: 8516729. DOI: 10.1161/HYPERTENSIONAHA.121.17298.

Clinical Characteristics of Resistant vs. Refractory Hypertension in a Population of Hypertensive Afrodescendants.

Macedo C, Junior R, Macedo I Arq Bras Cardiol. 2020; 115(1):31-39.

PMID: 32236323 PMC: 8384326. DOI: 10.36660/abc.20190218.

Raising the Bar in Renal Sympathetic Denervation Research and Reporting.

Lee J, Rick Turner J J Clin Hypertens (Greenwich). 2015; 18(2):89-94.

PMID: 26370742 PMC: 8031579. DOI: 10.1111/jch.12666.

References

Hering D, Mahfoud F, Walton A, Krum H, Lambert G, Lambert E . Renal denervation in moderate to severe CKD. J Am Soc Nephrol. 2012; 23(7):1250-7. PMC: 3380649. DOI: 10.1681/ASN.2011111062. View

Esler M, Jennings G, Korner P, Willett I, Dudley F, Hasking G . Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension. 1988; 11(1):3-20. DOI: 10.1161/01.hyp.11.1.3. View

Witkowski A, Prejbisz A, Florczak E, KADziela J, Sliwinski P, Bielen P . Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension. 2011; 58(4):559-65. DOI: 10.1161/HYPERTENSIONAHA.111.173799. View

Mahfoud F, Luscher T, Andersson B, Baumgartner I, Cifkova R, DiMario C . Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. Eur Heart J. 2013; 34(28):2149-57. DOI: 10.1093/eurheartj/eht154. View

Evelyn K, Alexander F, Cooper S . Effect of sympathectomy on blood pressure in hypertension; a review of 13 years' experience of the Massachusetts General Hospital. J Am Med Assoc. 1949; 140(7):592-602. DOI: 10.1001/jama.1949.02900420012004. View

Ukena C, Bauer A, Mahfoud F, Schreieck J, Neuberger H, Eick C . Renal sympathetic denervation for treatment of electrical storm: first-in-man experience. Clin Res Cardiol. 2011; 101(1):63-7. DOI: 10.1007/s00392-011-0365-5. View

Egan B, Zhao Y, Axon R, Brzezinski W, Ferdinand K . Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation. 2011; 124(9):1046-58. PMC: 3210066. DOI: 10.1161/CIRCULATIONAHA.111.030189. View

Geisler B, Egan B, Cohen J, Garner A, Akehurst R, Esler M . Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension. J Am Coll Cardiol. 2012; 60(14):1271-7. DOI: 10.1016/j.jacc.2012.07.029. View

Esler M, Krum H, Sobotka P, Schlaich M, Schmieder R, Bohm M . Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010; 376(9756):1903-9. DOI: 10.1016/S0140-6736(10)62039-9. View

10.

Converse Jr R, JACOBSEN T, Toto R, Jost C, Cosentino F, Victor R . Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1993; 327(27):1912-8. DOI: 10.1056/NEJM199212313272704. View

11.

GRIMSON K, ORGAIN E, Anderson B, BROOME R, LONGINO F . Results of Treatment of Patients with Hypertension by Total Thoracic and Partial to Total Lumbar Sympathectomy, Splanchnicectomy and Celiac Ganglionectomy. Ann Surg. 1949; 129(6):850-71. PMC: 1514176. View

12.

Esler M . The sympathetic system and hypertension. Am J Hypertens. 2000; 13(6 Pt 2):99S-105S. DOI: 10.1016/s0895-7061(00)00225-9. View

13.

Grassi G, DellOro R, Quarti-Trevano F, Scopelliti F, Seravalle G, Paleari F . Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia. 2005; 48(7):1359-65. DOI: 10.1007/s00125-005-1798-z. View

14.

Stella A, Zanchetti A . Functional role of renal afferents. Physiol Rev. 1991; 71(3):659-82. DOI: 10.1152/physrev.1991.71.3.659. View

15.

Prochnau D, Lucas N, Kuehnert H, Figulla H, Surber R . Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter. EuroIntervention. 2011; 7(9):1077-80. DOI: 10.4244/EIJV7I9A171. View

16.

Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt M . Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation. 2011; 123(18):1940-6. DOI: 10.1161/CIRCULATIONAHA.110.991869. View

17.

Krum H, Sobotka P, Mahfoud F, Bohm M, Esler M, Schlaich M . Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation. 2011; 123(2):209-15. DOI: 10.1161/CIRCULATIONAHA.110.971580. View

18.

Kandzari D, Bhatt D, Sobotka P, ONeill W, Esler M, Flack J . Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol. 2012; 35(9):528-35. PMC: 6652693. DOI: 10.1002/clc.22008. View

19.

GRIMSON K . TOTAL THORACIC AND PARTIAL TO TOTAL LUMBAR SYMPATHECTOMY AND CELIAC GANGLIONECTOMY IN THE TREATMENT OF HYPERTENSION. Ann Surg. 1941; 114(4):753-75. PMC: 1385824. DOI: 10.1097/00000658-194111440-00018. View

20.

Brandt M, Mahfoud F, Reda S, Schirmer S, Erdmann E, Bohm M . Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol. 2012; 59(10):901-9. DOI: 10.1016/j.jacc.2011.11.034. View